Cargando…
Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials
Target agents are peculiar oncological drugs which differ from the traditional therapies in their ability of recognizing specific molecules expressed by tumor cells and microenvironment. Thus, their toxicity is generally lower than that associated to chemotherapy, and they represent nowadays a new s...
Autores principales: | Tartari, Francesca, Conti, Alessandro, Cerqueti, Roy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567914/ https://www.ncbi.nlm.nih.gov/pubmed/28829823 http://dx.doi.org/10.1371/journal.pone.0183639 |
Ejemplares similares
-
The complex interplay between COVID-19 and economic activity
por: Cerqueti, Roy, et al.
Publicado: (2022) -
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
por: Pascarella, Giacomo, et al.
Publicado: (2019) -
A Universal Rank-Size Law
por: Ausloos, Marcel, et al.
Publicado: (2016) -
Combining rank-size and k-means for clustering countries over the COVID-19 new deaths per million
por: Cerqueti, Roy, et al.
Publicado: (2022) -
Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities
por: Krajewski, Katherine M., et al.
Publicado: (2017)